|Year : 2015 | Volume
| Issue : 44 | Page : 556-563
Bioactive extract from moringa oleifera inhibits the pro-inflammatory mediators in lipopolysaccharide stimulated macrophages
Masoumeh Tangestani Fard1, Palanisamy Arulselvan2, Govindarajan Karthivashan2, Siti Khadijah Adam1, Sharida Fakurazi3
1 Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia
2 Laboratory of Vaccines and Immunotherapeutics, Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
3 Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia; Laboratory of Vaccines and Immunotherapeutics, Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
|Date of Web Publication||31-Dec-2015|
Laboratory of Vaccines and Immunotherapeutics, Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Introduction: Inflammation is a well-known physiological response to protect the body against infection and restore tissue injury. Nevertheless, the chronic inflammation can trigger various inflammatory associated diseases/disorder. Moringa oleifera is a widely grown plant in most tropical countries and it has been recognized traditionally for several medicinal benefits. Objectives: The objective of this study was to investigate the anti-inflammatory properties of M. oleifera extract on lipopolysaccharide (LPS) - stimulated macrophages. Materials and Methods: The anti-inflammatory effect of M. oleifera hydroethanolic bioactive leaves extracts was evaluated by assessing the inhibition of nitric oxide (NO) production during Griess reaction and the expression of pro-inflammatory mediators in macrophages. Results: Interestingly, we found that M. oleifera hydroethanolic bioactive leaves extract significantly inhibited the secretion of NO production and other inflammatory markers such as prostaglandin E 2 , tumor necrosis factor alpha, interleukin (IL)-6, and IL-1b. Meanwhile, the bioactive extract has induced the production of IL-10 in a dose-dependent manner. In addition, M. oleifera hydroethanolic bioactive leaves extract effectively suppressed the protein expression of inflammatory markers inducible NO synthase, cyclooxygenase-2, and nuclear factor kappa-light-chain-enhancer of activated B-cells p65 in LPS-induced RAW264.7 macrophages in a dose-dependent manner. Conclusion: These findings support the traditional use of M. oleifera plant as an effective treatment for inflammation associated diseases/disorders.
Keywords: Anti-inflammatory, lipopolysaccharide, Moringa oleifera, pro-inflammatory, RAW264.7 murine macrophage
|How to cite this article:|
Fard MT, Arulselvan P, Karthivashan G, Adam SK, Fakurazi S. Bioactive extract from moringa oleifera inhibits the pro-inflammatory mediators in lipopolysaccharide stimulated macrophages
. Phcog Mag 2015;11, Suppl S4:556-63
|How to cite this URL:|
Fard MT, Arulselvan P, Karthivashan G, Adam SK, Fakurazi S. Bioactive extract from moringa oleifera inhibits the pro-inflammatory mediators in lipopolysaccharide stimulated macrophages
. Phcog Mag [serial online] 2015 [cited 2019 Dec 10];11, Suppl S4:556-63. Available from: http://www.phcog.com/text.asp?2015/11/44/556/172961
- Hydroethanolic extracts of Moringa oleifera effectively inhibit the NO production in LPS induced inflammatory model.
- M.oleifera crude extracts successfully modulate the production of pro-inflammatory mediators in LPS stimulated macrophages.
- M.oleifera extracts suppressed the expression of inflammatory mediators in LPS stimulated macrophages.
| Introduction|| |
Inflammation is a protective mechanism of organisms to defense against harmful stimuli. , It involves various molecular pathways with a wide variety of physiological processes.  However, up-regulated inflammation can lead to many diseases such as cancer,  asthma, allergic rhinitis, atopic dermatitis, and rheumatoid arthritis.  In the United States, inflammatory diseases were reported with the high prevalence among their population.  Around 46.4 million individuals were diagnosed with arthritis; 1.3 million adults and 294,000 children were reported for rheumatoid arthritis and juvenile arthritis, respectively.  Inflammation process of cellular dysfunction can be induced through microbial stimulus; lipopolysaccharide (LPS) is a common prototypical endotoxin can directly activate macrophages. Monitoring evidence have been recommended that activated macrophage produce a higher amount of inflammatory cytokines such as tumor necrosis factor alpha (TNF-a), interleukin (IL)-6, and other inflammatory mediators.  Macrophages produced by bone marrow cells are directed to different body organs and tissues such as lung and liver are closely connected with tissue homeostasis; moreover, it performed crucial role within the natural and acquired immune system. The macrophage is the foremost cell in the inflammatory process and exerts two opposite impacts, stimulatory and inhibitory effects on inflammation process, which include phagocytic effect based on the nature and intense of the stimulus. Macrophages, derived from blood (monocytes), are actively involved in tissue inflammation site against noxious insult; they are capable to perform a wide array of function. Inflammatory macrophages have the ability to kill through apoptosis, clearance of proliferating resident stromal, infiltrating leukocytes, and parenchymal cells. 
The World Health Organization has estimated that 80% of the population in the developing countries use traditional medicine for their primary health care needs and the majority of this therapy requires the use of herbal extract and their active components.  Almost all modern drugs are produced originally through traditional herbal resources. These have progressed to develop the conventional medicines that use both isolated natural compounds and synthetic drugs. Herbal supplements are popular and their formulations have led to the several novel generation of phytomedicines that are more effective than before.  Development of efficient nonsteroidal anti-inflammatory drugs (NSAIDs) with minimal or no gastrointestinal (GI) side effects is an area of interest in drug discovery industry. The use of most commonly recommended drug from analgesics such as aspirin currently have been restricted because of their potential side effects such as severe gastric disorders. Lesser gastrointestinal side effects seen with Cyclooxygenase -2 inhibitors are resolved at a slow phase. ,, Furthermore, an enhancement of cardiovascular and cerebrovascular events, specifically in patients with an increased risk of thrombosis has been evaluated in the chronic use of some COX-2-specific inhibitors. Anti-inflammatory drugs which include "biologicals" such as anti-cytokine therapies show a significant decrease in host defense toward the infection.  As a result of the steroidal and NSAID side effects, the researchers started to focus on natural compounds as a keen source of alternative drugs. Numerous herbal medicines pave the way for leading novel therapeutic compounds against inflammation, despite they are inexpensive, safe, highly tolerated, and convenient for numerous patients. ,
Moringa oleifera Lam (syn. Moringa pterygosperma known as "The Miracle Tree," "Horseradish-tree," or "Ben oil tree") is well-known and the most commonly spread species of Moringaceace family. It offers a remarkable range of medicinal application due to its possession of numerous nutritional/therapeutic candidates. M. oleifera grows through the diverse part of the world Asia, Africa, India, Pakistan, Cambodia, Philippines, and America.  Different parts of the plant extracts and derived compounds have been reported with various medicinal properties. The root extract has been demonstrated to have anti-fertility and anti-inflammatory agents. Moreover, the seed possesses anti-inflammatory impact, anti-hypertensive effects, and ability to decrease lipid peroxidation. Moringa Leaves extract have been studied for its antioxidant effect through various in vitro and in vivo approaches and also it has various pharmacological properties such as hypolipidemic, anti-atherosclerotic,  wound healing,  hepatoprotective, ,, antimicrobial, antinociceptive, and radioprotective properties.  These extracts have eliminated the neuropathic pain , and protection against oxidative stress in an in vivo model of Alzheimer's disease.  The pods, leaves, and flowers of M. oleifera commonly have been consumed as a vegetable in the south of Asia. Since, the whole plant provides nutrition and medicinal value against diabetes, cancer, rheumatoid arthritis, and other ailments; M. oleifera is also called as "miracle tree."  The reason behind the enormous pharmacological activities of M. oleifera might possibly due to various secondary plant metabolites present in M. oleifera such as flavonoids, phenolics, vitamins, carotenoids, minerals, sterols, amino acids, alkaloids, and glycosides.  M. oleifera leaves contains phenolic acids such as quinic acid and chlorogenic acid that exhibit high antioxidant activities , and recently b-sitosterol, was isolated from Moringa leaves fraction  and it has reported to reduce the intestinal uptake of dietary cholesterol effects.  M. oleifera seeds contains antitumor and anti-hypertensive effects of O-ethyl-4-(a-L-rhamnosyloxy) benzyl carbamate and its seven derivatives such as niazirin, niazimicin, and b-sitosterol.  Therefore, the purpose of this study was to screen three different hydroethanolic solvent gradients of M. oleifera bioactive leaves extract for cytotoxicity and NO production. Furthermore, the anti-inflammatory activity of M. oleifera hydroethanolic bioactive leaves extract in LPS-stimulated RAW264.7 murine macrophage cells was evaluated by quantifying the expression of various inflammatory markers in comparison with dexamethasone, a known anti-inflammatory compound.
| Materials And Methods|| |
Chemicals and reagents
The murine macrophage RAW264.7 cell line (ATCC, TIB-71) was examined as an in vitro model to investigate the anti-inflammatory properties of M. oleifera hydroethanolic extract. Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS), penicillin, streptomycin for cell culture were obtained from Nacalai (Kyoto, Japan). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), LPSs isolated from Escherichia coli 0111:B4 were purchased from Sigma-Aldrich Co., (St. Louis, MO, USA). Prostaglandin E 2 (PGE 2 ) parameter assay kit, TNF-a, IL-6, IL-1b, and IL-10 mouse ELISA kits were purchased from R and D Systems (Minneapolis, MN, USA). The bicinchoninic acid (BCA) protein assay kit was obtained from Pierce (Thermo scientific, USA). Anti-b-actin-horseradish peroxidase (HRP) and secondary polyclonal antibody-conjugated HRP, were purchased from Santa Cruz (CA, USA). Primary antibodies against inducible nitric oxide synthase (iNOS), COX-2, nuclear factor kappa-light-chain-enhancer of activated B-cells p65 (NFkB-p65), were purchased from Abcam (Cambridge, MA, USA).
Preparation of plant extract
Fresh and mature M. oleifera leaves were collected from Garden-2, Universiti Putra Malaysia, Serdang, Selangor, Malaysia, washed and dried at room temperature for 18 h. Then, the leaves were oven dried at 42°C for 2 consecutive days and grinded them with electronic laboratory blender. Three different hydroethanolic solvent gradients were prepared (ethanol: Distilled water, 50:50 [50%], 70:30 [70%], and 90:10 [90%]), and they were macerated for 3 days at room temperature. The soaked material was stirred every day and filtered through filter paper. Then, the extract obtained from maceration process was concentrated under vacuum on a rotary evaporator at 40°C. The crude extract was freeze-dried, weighed, and stored at −80°C for future use. For each experiment prior to the treatment of cell culture, M. oleifera hydroethanolic extract was dissolved in DMEM and sonicated in an ultrasonic bath (Mettler Electronic Corporation, Anaheim, USA) at 25°C.
Murine RAW264.7 macrophage cell line was purchased from ATCC (VA, USA) and cultured in DMEM supplemented with 10% FBS, 1% streptomycin/penicillin at 37°C in a 5% CO 2 incubator. Dexamethasone, which is commonly known as a classic glucocorticosteroid drug and frequently used in clinical practice, was selected as a positive control with a concentration of 0.5 mg/ml.  RAW264.7 macrophage cells stimulated by LPS (1 mg/ml) without any other intervention component were considered as a negative control  while cells incubated by medium were considered as normal control.
3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide assay for cell viability
The effect of M. oleifera hydroethanolic bioactive leaves extract on cell viability was measured by the mitochondrial-dependent reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-bromide (MTT) to violet formazan crystals (nonwater-soluble) inside the cell. The cells were cultured in 96-well plates at a density of 10 5 cells/ml (100 mL/well) and incubated for 24 h. Cells were treated with three different hydroethanolic gradients (50%, 70%, and 90%) with different concentrations through serial dilution (1000-15.62 mg/ml) and this was followed by 24 h incubation. Then, 20 ml MTT solution at 37°C was added (5 mg/ml in phosphate-buffered saline) with 4 h incubation. The optical density of formazan in solution was measured by using microplate reader at 570 nm wavelength.
Determination of nitric oxide
The effects of M. oleifera hydroethanolic bioactive leaves extract on NO production in RAW264.7 cells were determined based on Griess reaction. In brief, RAW264.7 cells were cultured in 24-well plates at a density of 10 5 /ml and incubated for 24 h followed by 1-h pretreatment with M. oleifera hydroethanolic (50%, 70%, and 90%) extract and dexamethasone and co-incubated with LPS for 24 h. Griess reagent (0.1% N-[1-naphthyl] ethylenediamine-HCl and 1% sulfanilamide and 5% H 3 PO 4 ) was added to the supernatant and after 10 min incubation reading by ELISA microplate reader at 540 nm wavelength.
Determination of inflammatory mediator's by ELISA
Cells (1 × 10 6 cells/ml) were plated into 6-well culture plate and treated with M. oleifera 90% hydroethanolic bioactive leaves extract or dexamethasone, then stimulated for 24 h with LPS. In brief, capture antibodies for TNF-a, IL-6, IL1-b, and IL-10 were coated in 96-well plates by overnight incubation. After the incubation time and washing immune complex of capture antibody, samples/standard, and detection antibody. Finally, plates were detected by reacting with streptavidin horseradish - HRP - tetramethylbenzidine detection system. Reactions were stopped by addition of 2M H 2 SO 4 , and absorbance was read at 450 nm by a microplate reader. In addition, PGE 2 production was determined using an ELISA kit (with coated capture antibody) according to the manufacturer's instructions.
Western blot analysis
The cells were cultured in 6-well plates and incubated with M. oleifera 90% hydroethanol bioactive leaves extract in the presence and the absence of LPS for 24 h. After washing with ice-cold phosphate buffer saline (PBS), the cells were lysed in a cell lysis buffer containing the protease and phosphatase inhibitor cocktail. Cells lysed dilution was centrifuged at 14,000 rpm for 25 min to discard cell debris. The protein concentration was measured by using BCA assay according to the manufacture's instruction. Equal amounts of total cellular proteins (30 mg) were resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a polyvinylidene fluoride membrane (GE Healthcare, USA). Each membrane was incubated with blocking solution (5% nonfat skim milk) in PBS containing 0.5% Tween 20 (PBST, pH 7.4) at room temperature for 1-h. This was followed by an overnight incubation at 4°C with the appropriate primary antibodies iNOS, COX-2, NFkB-p65 (1:1000 dilution), the membranes were washed with PBS containing Tween 20 for 1-h, then incubated with a 1:2000 dilution of HRP-conjugated secondary antibodies for 1-h at room temperature. The membranes were washed again with PBST for 1-h then the immune reacted proteins were detected using a Chemiluminescence System (ChemiDoc, BioRad, USA). The bands obtained were quantitated and analyzed using ImageJ Software (BioTechniques, New York, NY, USA).
The results reported are summarized from three independent experiments and expressed as the mean ± standard deviation (SD). Data were presented as means ± SD and the P < 0.05 and P < 0.001 were considered as statistically significant. Significant differences were examined using an analysis of variance with SPSS 20.0 software (SPSS Inc., Chicago, IL, USA).
| Results|| |
Effect of Moringa oleifera on cell viability
Three different hydroethanolic gradients of M. oleifera bioactive leaves extract were examined for cytotoxicity study with MTT assay. The 90% hydroethanolic extract showed the highest cell viability and more than 85% of the cells were viable at 125 mg/ml and 250 mg/ml concentrations (*P < 0.05) [Figure 1]. Accordingly, (90:10) 90% M. oleifera hydroethanolic bioactive leaves extract at 250, 125 mg/ml concentrations was selected for future anti-inflammatory experiments.
|Figure 1: The effect of three different hydroethanolic gradients of Moringa oleifera leaves extract (90%, 70%, and 50%) on the viability of RAW 264.7 cells. Cytotoxicity was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction assay after 24 h treatment with Moringa oleifera extract (15.62-1000) µg/ml. Values are presented as the mean of three independent experiments in triplicate, and data are shown as mean ± standard deviation. Statistical analysis using one-way analysis of variance with Tukey's post-hoc test (*P < 0.05) as compared with the untreated control group|
Click here to view
Inhibition of nitric oxide production by Moringa oleifera in lipopolysaccharide-stimulated RAW264.7 cells
RAW264.7 murine macrophage cells were shown to produce NO through stimulation with LPS. Significant inhibition of NO production was observed after treatment with three different hydroethanolic gradients of M. oleifera bioactive leaves extract. In addition, NO production was significantly suppressed after treatment with dexamethasone (*P < 0.001) [Figure 2].
|Figure 2: Effects of three different hydroethanolic gradients of Moringa oleifera bioactive leaves extract (90%, 70%, and 50%) on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophage. Cells were treated with different concentration of Moringa oleifera (62 µg/ml, 125 µg/ml, and 250 µg/ml) in the presence of 1 µg/ml lipopolysaccharide for 24 h. Dexamethasone (0.5 µg/ml) was used as a positive control. Control values were obtained in the absence of lipopolysaccharide or Moringa oleifera. Three independent assays were performed in triplicate, and data are shown the mean ± standard deviation statistical analysis using one-way analysis of variance with Tukey's post-hoc test. (*P < 0.001) indicates significant differences from the lipopolysaccharide treated group and nontreated group|
Click here to view
The effect of Moringa oleifera on lipopolysaccharide-induced inflammatory cytokines and prostaglandin E 2 production
The cytokine production levels of TNF-a, IL-1b, IL-6, and PGE 2 in the cell-free culture supernatants were significantly enhanced in respond to LPS induction [Figure 3]a-d, which has proven the successful establishment of in vitro inflammatory model. The 90% M. oleifera hydroethanolic bioactive leaves extract significantly suppressed the production level of TNF-a, IL-1b, IL-6, and PGE 2 in a concentration-dependent manner (*P < 0.001) (**P < 0.001) ( #P < 0.05) [Figure 3]a-d and meantime, it has increased the production of IL-10 in a dose-dependent manner (*P < 0.001) [Figure 3]e. Meanwhile, dexamethasone has also exhibited the significant inhibition in TNF-a, IL-1b, IL-6, PGE 2 production, and enhancement in IL-10 level (*P < 0.001) (**P < 0.001) ( #P < 0.05) [Figure 3]a-e.
|Figure 3: (a-e) Effect of Moringa oleifera 90% hydroethanolic bioactive leaves extract on the production of tumor necrosis factor alpha, interleukin-1β, interleukin-6, prostaglandin E2, and interleukin-10 cytokines in lipopolysaccharide-stimulated RAW 264.7 cells. Cells have been exposed with lipopolysaccharide (1 µg/ml) alone or lipopolysaccharide plus different concentrations of Moringa oleifera (125 µg/ml, 250 µg/ml) and dexamethasone for 24 h. Three independent assays were performed in triplicate, and the data are shown the mean ± standard deviation statistical analysis using one-way analysis of variance with Tukey's post-hoc test. It shows a significant difference with lipopolysaccharide treated and untreated groups (*P < 0.001). It exhibits significant difference with lipopolysaccharide treated group (**P < 0.001). It shows a significant difference with lipopolysaccharide treated group (#P < 0.05)|
Click here to view
Effect of Moringa oleifera on expression of inflammatory markers inducible nitric oxide synthase, cyclooxygenase-2, and nuclear factor kappa-light-chain-enhancer of activated B-cells p65 on lipopolysaccharide-induced macrophages
Western blot analysis was performed to evaluate the inhibitory effects of M. oleifera on inflammatory mediators in LPS stimulated macrophages. RAW264.7 cells were treated with 90% M. oleifera hydroethanolic bioactive leaves extract in the presence and the absence of LPS for 24 h. The protein expression of iNOS and COX-2 was clearly enhanced through stimulation with LPS, and M. oleifera hydroethanolic bioactive leaves extract considerably suppressed iNOS and COX-2 pro-inflammatory mediators, and NFkB-p65 protein expression in a dose-dependent fashion [Figure 4]a. In addition, to understand whether M. oleifera hydroethanolic bioactive leaves extract suppressed NF-kB pathway activity, we measured the protein expression of NFkB-p65 and it exhibited significant inhibition effect through LPS stimulated RAW264.7 cells. In the quantitative determination, b-actin expression level as an internal standard was comparable between each target protein. The density ratio of iNOS, COX-2, and NFkB-p65 was significantly decreased after treatment with M. oleifera through LPS-induced RAW264.7 cells (*P < 0.05) [Figure 4]b.
|Figure 4: (a) Effect of Moringa oleifera hydroethanolic bioactive leaves extract on lipopolysaccharide-induced inducible nitric oxide synthase, cyclooxygenase-2, and nuclear factor kappa-light-chain-enhancer of activated B-cells p65 expression in RAW264.7 cells. Cells were stimulated with lipopolysaccharide (1 µg/ml) in the presence of Moringa oleifera hydroethanolic leaves extract (125 µg/ml, 250 µg/ml) and dexamethasone (0.5 µg/ml) for 24 h at 37°C. Cell lysates were extracted, and protein expression levels were analyzed by Western blot. β-actin was used as the loading control. (b) The level of each protein was measured and normalized to β-actin. The values are reported as the mean ± standard deviation percentage of three independent experiments. Statistical analysis using one-way analysis of variance with Tukey's post-hoc test. It shows a significant difference with lipopolysaccharide treated group (*P < 0.05)|
Click here to view
| Discussion|| |
Macrophages perform a crucial function in host defenses toward noxious substances and the inflammation process. ,,,,, It has been well-established that LPS, a part of Gram-negative bacteria membranes is identified by toll-like receptor 4 (TLR4) on the cell membrane of the macrophages. It activates the release of pro-inflammatory mediators through TLR4-NFkB signaling pathways, which mediate host harmful injury.  Overproduction of pro-inflammatory cytokines by activated macrophages has been concerned in the pathophysiology of numerous chronic inflammatory illnesses. Therefore, LPS-stimulated macrophages are used as a model to investigate on inflammation and the mechanisms action of anti-inflammatory agents. , Recently, it has been notable that more natural products are becoming utilized as a treatment to reduce several acute and chronic diseases. ,
In the field of natural products drug discovery, plant extractions process with the appropriate solvent system is very essential to identify and isolate the pharmacological compounds from medical plants. A previous investigation by Fakurazi et al.,  has been reported that hepatoprotective properties of 80% hydroethanolic M. oleifera leaves extract in hepatotoxicin induced animal model. However, in the present study, we have evaluated three different hydroethanolic gradients of M. oleifera leaves extracts based on cell specific toxicity, anti-oxidant, and anti-inflammatory properties.  Several anti-inflammatory drugs have recently been exhibited to carry a free radical scavenging mechanism as part of their pharmacological activities.  Oxidative stress-induced activation of NFkB has been identified in several chronic inflammatory diseases exhibiting a crucial link among modulation of NFkB molecules and antioxidant properties.  Furthermore, it could be suggested that antioxidant potential of M. oleifera leaves might be one of the cellular mechanisms of its anti-inflammatory potential in LPS stimulated macrophages. ,,
Cell viability assay was performed for three different M. oliefera hydroethanolic leaves gradients 90% hydroethanolic bioactive leaves extract revealed the highest cell viability as compared with 70% and 50% concentration. It can be due to the availability of more nutrition and some certain compounds for cells. This result was in agreement with our previous study by Karthivashan et al.,  which introduced 90% hydroethanolic solvent as the best solvent. It could possibly digest leaves tissue and may release antioxidant and nutritionally important active compounds of M. oliefera leaves. Consistent with the previous findings by Araϊjo et al.,  indicated that M. oleifera aqueous seeds extract also exhibited higher cell viability on peritoneal macrophages cells. Previous investigations have shown that, the maximum duration of release of inflammatory mediators from LPS stimulated macrophages was 24 h with 1 mg/ml concentration and this LPS concentration is nontoxic to macrophages. ,,,
NO is an essential mediator and regulator of inflammatory responses. In the inflammatory processes overproduction of NO reacts with superoxide causes cytotoxicity and tissue damage in several organisms. NO-induced oxidative stress is associated with several illnesses for instance atherosclerosis, septic shock, diabetes, Alzheimer's disease, and Parkinson's disease. NO inhibitor compounds have been reported as an effective treatment for such diseases.  In animal tissues synthases enzyme (NOS) oxidase L-arginine to L-citrulline and produce NO supplements. Three isoforms of NOS which include NOS I or (nNOS) - the neuronal form, NOS II or iNOS, contained in numerous cell types following inflammatory stimulation (e.g., macrophages), and NOS III (or eNOS) - constitutive enzyme mainly reveal in the endothelium. The three isoforms have the same molecular construction and involve numerous cofactors.  Recent study by Lee, et al. has demonstrated that licochalcone E which is isolated and characterized from the roots of Glycyrrhiza inflata, revealed potent anti-inflammatory effect by suppressing NO production and protein expression of iNOS in a dose-dependent fashion.  In this study, the effect of three different hydroethanolic M. oliefera leaves gradients (50:50 [50%], 70:30 [70%], and 90:10 [90%]) were found to significantly inhibit LPS-induced NO production. Moreover, the inhibitory effect of positive control (dexamethasone) was similar to M. oleifera leaves extract. In addition, protein expression of NOS was inhibited after treatment with M. oleifera hydroethanolic bioactive leaves extract confirming the suppressive effect of M. oleifera on NO production. These findings might conclude that M. oleifera leaves acts as an effective anti-inflammatory agent against various ailments.
The mechanism of action of numerous anti-inflammatory drugs is through PG synthesis suppression which usually mediated by COX. Between two isoforms of COX (COX-1 and COX-2), COX-1 has been recommended to produce a physiological amount of PGs for typical platelet, kidney, and stomach function. COX-2 is a mediator with high activity at inflammatory sites in animals and human patients with the inflammatory disorder.  PGE 2 is one of the most effective inflammatory mediators which acts in all inflammatory processes leading to typical signs of inflammation such as pain, swelling, and redness.  PGE 2 has been altered from arachidonic acid through the COX-2 catalytic activity. COX-2 also might be affected specifically at its enzymatic activity via NO and NOS. A recent study by Kim et al., has exhibited that composition of essential oil from fingered citron (Citrus medica L. var. sarcodactylis) caused dose-dependent suppression of LPS-stimulated PGE 2 production and inhibited COX-2 protein expression.  In this study M. oleifera hydroethanolic bioactive leaves extracts significantly reduced PGE 2 production and COX-2 protein expression. It may suggest that the anti-inflammatory effect of M. oleifera hydroethanolic bioactive leaves extracts could possibly be due to its suppressive effect on PGE 2 production via blocking COX-2 protein expression. The cross-talk among the iNOS and COX-2 pathways has been identified through several researchers and few researches have concluded that NO seems to reduce COX-2 expression.  Targeting iNOS and COX-2 has been known as a useful strategy to prevent acute and chronic inflammatory diseases. These inflammatory mediators regulate the inflammation process by producing NO and PGE 2 , respectively.  As a result active compounds with dual suppression effects on iNOS and COX-2 expression would have remarkable potential on healing the acute and chronic inflammation.
Pro-inflammatory cytokines, which includes TNF-a and IL-6 are classified as main inflammatory mediators which are produced by monocyte and macrophages in the inflammatory procedure.  TNF-a is a key mediator in inflammatory responses, as well as the initiation of apoptosis. It might stimulate the development or expression of IL-6, IL-1b, PGE 2 , collagenase, and adhesion molecules eliciting a variety of physiological functions such as septic shock, inflammation and cytotoxicity.  In addition, it represents a function on the developmental pathogenesis of numerous inflammation-associated chronic illnesses such as cancer, obesity, and cardiovascular diseases. TNF-a and IL-6 are mainly produced by macrophages in response to LPS through NFkB activation.  The IL-1 family plays a crucial role in both host defense and inflammation. To date, up to 11 members of this family have been recognized. IL-1a and IL-1b both are synthesized as precursor molecules by several different cell types and both are pro-inflammatory cytokines. IL-1b is a main mediator of inflammation which performs a basic role in tissue injury restore along with protection toward microbial pathogens. In these conditions, systemic (i.e. bone marrow) and/or local (i.e., endothelial) reactions to this cytokine are responsible for beneficial impacts, which include cellular infiltration and neutrophil mobilization, respectively. However, an extra amount of this cytokine may possibly have deleterious impacts on a diversity of cells and tissue.  IL-6, which has been originally defined as a B-cell differentiation factor is regarded as a multifunctional cytokine which regulates immune responses, hematopoiesis, acute phase response, and inflammation. Increased IL-6 amount in many cases is correlated with several diseases which include rheumatoid arthritis, systemic-onset juvenile chronic arthritis, osteoporosis, psoriasis, polyclonal plasmacytosis, malignant plasmacytoma, Crohn's disease, and encephalomyelitis. Therefore, inhibitors of IL-6 could possibly be beneficial in treating of inflammatory autoimmune illnesses.  A recent study has been published on anti-inflammatory properties of plumbagin, derived from the plants of the Plumbaginaceae family which exhibited suppressing effect on the production of TNF-a, IL-1b, and IL-6 from LPS-stimulated RAW264.7 cells in a dose-dependent fashion.  In the present study, M. oleifera hydroethanolic bioactive leaves extract exhibited significant inhibition in LPS-induced TNF-a, IL-1 b, and IL-6 production in a dose-dependent manner. These results recommended that M. oleifera leaves may possess anti-inflammatory characteristic and help to reduce some inflammatory associated disorders. We believe that these anti-inflammatory properties of M. oleifera bioactive leaves extracts might be related to the presence of various active compounds which was identified by us through liquid chromatography-mass spectrometry (MS)/MS. 
IL-10 is one of the pleiotropic cytokines, which regulated the function of numerous adaptive immune-related cells. Although, IL-10 is strongly known as an immunosuppressive and anti-inflammatory cytokine, it performs other crucial roles such as the ability to activate B-cells, T-cells, natural killer cells, and mast cells.  A study by Zhao, et al. has reported that Corilagin (beta-1-O-galloyl-3,6-(R)-hexa hydroxyl diphenoyl-D-glucose) a member of the tannin family significantly enhanced IL-10 production in a dose-dependent manner through LPS stimulated RAW264.7 cells.  In the current study, M. oleifera hydroethanolic bioactive leaves extract revealed significant induction in IL-10 amount as an anti-inflammatory cytokine in a dose-dependent fashion which was in agreement with anti-inflammatory properties of M. oleifera bioactive extract.
NFkB characteristics as a hetero- or homo-dimer, which is often classify in five NFkB subunits NFkB1 (p50 and its precursor p105), NFkB2 (p52 and its precursor p100), RelA (p65), RelB, and c-Rel. Among all, p50:p65 is the most studied heterodimers, which are activated through the classical pathway and basically stimulated gene expression. The transcription factor NFkB is often a crucial regulator of numerous cellular functions such as cell survival and inflammation. Interestingly, for this kind of functions the role of p50:p65 dimer is most highlighted. Moreover, cell survival and inflammation stimulation are related to the p50:p65 dimer function.  In resting cells NFkB is situated in the cytoplasm as a nonactive complex bound to I-kBa, as an inhibitory protein. When cells become activated through inflammatory stimuli the inhibitory protein is phosphorylated and consequently degraded then, dissociated to provide free NFkB. As a result, free NFkB will translocate into the nucleus where it connected to kB binding sites in the promoter part of target genes. Basically, transcription of pro-inflammatory markers increases through this binding connection. Therefore, suppression of NFkB signaling pathway production might describe the potent activity of M. oleifera bioactive leaves extract as an inhibitor of inflammatory cytokines and mediators. Basically, NFkB factor p65 after stimulation with LPS translocate from the cytoplasm to the nucleus.  In the current study, we found that the translocation of NFkB factor p65 was significantly inhibited by M. oleifera bioactive leaves extract in a dose-dependent fashion. It could be recommended that the anti-inflammatory impact of M. oleifera bioactive leaves extract is through NFkB pathway inhibition.
| Conclusion|| |
Although a few immunotherapy studies on M. oleifera have been reported in the past the anti-inflammatory activity of M. oleifera hydroethanolic bioactive leaves extracts was first explored. The current study demonstrated that M. oleifera hydroethanolic bioactive leaves extract exhibited a remarkable anti-inflammatory effect on LPS induced inflammation in macrophages. Bioactive extract of M. oleifera effectively suppressed iNOS and COX-2 protein expression and also the production of NO and PGE 2 stimulated by LPS. Moreover, it decreased the pro-inflammatory cytokines production (TNF-a, IL-1b, and IL-6) induced by LPS in macrophages, and the level of IL-10 was increased through suppression of signaling cascades leading to the activation of NFkB-p65. In addition, this study suggested that the anti-inflammatory activity from bioactive compounds contain in M. oleifera hydroethanolic bioactive leaves extract can promote effective treatment to manage the inflammatory disorder.
Financial support and sponsorship
This work was supported by a research grant from the Ministry of Science, Technology and Innovation of Malaysia under E-science Project No 02-01-04-SF1144 and the Ministry of Agriculture Malaysia under science fund (agriculture section) No. 05-01-04-SF1148.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Huo M, Cui X, Xue J, Chi G, Gao R, Deng X, et al.
Anti-inflammatory effects of linalool in RAW 264.7 macrophages and lipopolysaccharide-induced lung injury model. J Surg Res 2013;180:e47-54.
Kim KN, Ko YJ, Yang HM, Ham YM, Roh SW, Jeon YJ, et al.
Anti-inflammatory effect of essential oil and its constituents from fingered citron (Citrus medica
L. var. sarcodactylis) through blocking JNK, ERK and NF-kB signaling pathways in LPS-activated RAW 264.7 cells. Food Chem Toxicol 2013;57:126-31.
Dinarello CA. Anti-inflammatory agents: Present and future. Cell 2010;140:935-50.
Rajput S, Wilber A. Roles of inflammation in cancer initiation, progression, and metastasis. Front Biosci (Schol Ed) 2010;2:176-83.
Chu X, Ci X, Wei M, Yang X, Cao Q, Guan M, et al.
Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro
and in vivo
. J Agric Food Chem 2012;60:3947-54.
Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al.
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008;58:15-25.
Naik SR, Wala SM. Inflammation, allergy and asthma, complex immune origin diseases: Mechanisms and therapeutic agents. Recent Pat Inflamm Allergy Drug Discov 2013;7:62-95.
Alhakmani F, Kumar S, Khan SA. Estimation of total phenolic content, in-vitro
antioxidant and anti-inflammatory activity of flowers of Moringa oleifera
. Asian Pac J Trop Biomed 2013;3:623-7.
Agnihotri S, Wakode S, Agnihotri A. An overview on anti-inflammatory properties and chemo-profiles of plants used in traditional medicine. Indian J Nat Prod Resour 2010;1:150-67.
Dutt V, Dutt R, Kumar S, Dhar V. Evaluation of analgesic activity of Solanum platanifolium
sims of fruits. Indian Drugs Bombay 2007;44:405.
Chhabria M, Doda S, Jani M. Synthesis and anti-inflammatory activity of some novel 2-Phenyl-3-Methylthio-3-(substituted) arylamino acrylamide. Indian Drugs Bombay 2005;42:604.
Park EK, Ryu MH, Kim YH, Lee YA, Lee SH, Woo DH, et al.
Anti-inflammatory effects of an ethanolic extract from Clematis mandshurica
Rupr. J Ethnopharmacol 2006;108:142-7.
Wei WC, Lin SY, Chen YJ, Wen CC, Huang CY, Palanisamy A, et al.
Topical application of marine briarane-type diterpenes effectively inhibits 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and dermatitis in murine skin. J Biomed Sci 2011;18:94.
Luqman S, Srivastava S, Kumar R, Maurya AK, Chanda D. Experimental assessment of Moringa oleifera
Leaf and fruit for its antistress, antioxidant, and scavenging potential using in vitro
and in vivo
assays. Evid Based Complement Alternat Med 2012;2012:519084.
Muangnoi C, Chingsuwanrote P, Praengamthanachoti P, Svasti S, Tuntipopipat S. Moringa oleifera
pod inhibits inflammatory mediator production by lipopolysaccharide-stimulated RAW 264.7 murine macrophage cell lines. Inflammation 2012;35:445-55.
Muhammad AA, Pauzi NA, Arulselvan P, Abas F, Fakurazi S. In vitro
wound healing potential and identification of bioactive compounds from Moringa oleifera
Lam. Biomed Res Int 2013;2013:974580.
Fakurazi S, Sharifudin SA, Arulselvan P. Moringa oleifera
hydroethanolic extracts effectively alleviate acetaminophen-induced hepatotoxicity in experimental rats through their anti-oxidant nature. Molecules 2012;17:8334-50.
Kumar E, Harsha K, Shaik S, Rao NN, Giribabu N. Evaluation of in vitro
antioxidant activity and in vivo
hepatoprotective activity of Moringa oleifera
seeds extract against ethanol induced liver damage in wistar rats. Evaluation 2013;3:10-5.
Ujah O, Ujah I, Johnson J, Ekam V, Udenze E. Hepatoprotective property of ethanolic leaf extract of Moringa oleifera
on carbon tetrachloride (CCl4) induced hepatotoxicity. J Nat Prod Plant Resour 2013;3:15-22.
Bhattacharya A, Naik MR, Agrawal D, Sahu PK, Kumar S, Mishra SS. CNS Depressant and muscle relaxant effect of ethanolic leaf extract of Moringa oleifera
on albino rats. Int J PharmTech Res 2014;6:1441-9.
Khongrum J, Wattanathorn J, Muchimapura S, Thukhum-Mee W, Thipkaew C, Wannanon P, et al. Moringa oleifera
Leaves extract attenuates neuropathic pain induced by chronic constriction injury. Am J Appl Sci 2012;9:1182-7.
Kirisattayakul W, Wattanathorn J, Tong-Un T, Muchimapura S, Wannanon P. Moringa oleifera
Lam mitigates oxidative damage and brain infarct volume in focal cerebral ischemia. Am J Appl Sci 2012;9:1457-63.
Hannan MA, Kang JY, Mohibbullah M, Hong YK, Lee H, Moringa oleifera
with promising neuronal survival and neurite outgrowth promoting potentials. J Ethnopharmacol 2014;152:142-50.
Chumark P, Khunawat P, Sanvarinda Y, Phornchirasilp S, Morales NP, Phivthong-Ngam L, et al.
The in vitro
and ex vivo
antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract of Moringa oleifera
Lam. leaves. J Ethnopharmacol 2008;116:439-46.
Amaglo NK, Bennett RN, Lo Curto RB, Rosa EA, Lo Turco V, Giuffrida A, et al.
Profiling selected phytochemicals and nutrients in different tissues of the multipurpose tree Moringa oleifera L
. grown in Ghana. Food Chem 2010;122:1047-54.
Mbikay M. Therapeutic potential of Moringa oleifera
Leaves in chronic hyperglycemia and dyslipidemia: A review. Front Pharmacol 2012;3:24.
Jain PG, Patil SD, Haswani NG, Girase MV, Surana SJ. Hypolipidemic activity of Moringa oleifera
Lam. Moringaceae, on high fat diet induced hyperlipidemia in albino rats. Rev Bras Farmacognosia 2010;20:969-73.
Lin X, Racette SB, Lefevre M, Spearie CA, Most M, Ma L, et al.
The effects of phytosterols present in natural food matrices on cholesterol metabolism and LDL-cholesterol: A controlled feeding trial. Eur J Clin Nutr 2010;64:1481-7.
Preedy VR, Watson RR, Patel VB. Nuts and Seeds in Health and Disease Prevention. London, Burlington, San Diego: Academic Press; 2011.
Zhao L, Zhang SL, Tao JY, Pang R, Jin F, Guo YJ, et al.
Preliminary exploration on anti-inflammatory mechanism of Corilagin (beta-1-O-galloyl-3,6-(R)-hexahydroxydiphenoyl-D-glucose) in vitro
. Int Immunopharmacol 2008;8:1059-64.
Zhang X, Xiong H, Liu L. Effects of taraxasterol on inflammatory responses in lipopolysaccharide-induced RAW 264.7 macrophages. J Ethnopharmacol 2012;141:206-11.
Sellamuthu PS, Arulselvan P, Kamalraj S, Fakurazi S, Kandasamy M. Protective nature of mangiferin on oxidative stress and antioxidant status in tissues of streptozotocin-induced diabetic rats. ISRN Pharmacol 2013;2013:750109.
Huang YT, Wen CC, Chen YH, Huang WC, Huang LT, Lin WC, et al.
Dietary uptake of Wedelia chinensis
extract attenuates dextran sulfate sodium-induced colitis in mice. PLoS One 2013;8:e64152.
Fakurazi S, Hairuszah I, Nanthini U. Moringa oleifera
Lam prevents acetaminophen induced liver injury through restoration of glutathione level. Food Chem Toxicol 2008;46:2611-5.
Karthivashan G, Tangestani Fard M, Arulselvan P, Abas F, Fakurazi S. Identification of bioactive candidate compounds responsible for oxidative challenge from hydro-ethanolic extract of Moringa oleifera
leaves. J Food Sci 2013;78:C1368-75.
Mehta JP, Parmar PH, Vadia SH, Patel MK, Tripathi CB. In vitro
antioxidant and in vivo
anti-inflammatory activities of aerial parts of Cassia
species. Arabian J Chem 2013. doi:10.1016/j.arabjc.2013.06.010.
Siriwatanametanon N, Fiebich BL, Efferth T, Prieto JM, Heinrich M. Traditionally used Thai medicinal plants: In vitro
anti-inflammatory, anticancer and antioxidant activities. J Ethnopharmacol 2010;130:196-207.
Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-85.
Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med 2010;49:1603-16.
Araújo LC, Aguiar JS, Napoleão TH, Mota FV, Barros AL, Moura MC, et al.
Evaluation of cytotoxic and anti-inflammatory activities of extracts and lectins from Moringa oleifera
seeds. PLoS One 2013 9;8:e81973.
Xiong H, Cheng Y, Zhang X, Zhang X. Effects of taraxasterol on iNOS and COX-2 expression in LPS-induced RAW 264.7 macrophages. J Ethnopharmacol 2014;155:753-7.
Yuan F, Chen J, Sun PP, Guan S, Xu J. Wedelolactone inhibits LPS-induced pro-inflammation via NF-kappaB pathway in RAW 264.7 cells. J Biomed Sci 2013;20:84.
Soromou LW, Zhang Z, Li R, Chen N, Guo W, Huo M, et al.
Regulation of inflammatory cytokines in lipopolysaccharide-stimulated RAW 264.7 murine macrophage by 7-O-methyl-naringenin. Molecules 2012;17:3574-85.
Bae DS, Kim YH, Pan CH, Nho CW, Samdan J, Yansan J, et al.
Protopine reduces the inflammatory activity of lipopolysaccharide-stimulated murine macrophages. BMB Rep 2012;45:108-13.
Li C, Wang MH. Anti-inflammatory effect of the water fraction from hawthorn fruit on LPS-stimulated RAW 264.7 cells. Nutr Res Pract 2011;5:101-6.
Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003;54:469-87.
Lee HN, Cho HJ, Lim do Y, Kang YH, Lee KW, Park JH. Mechanisms by which licochalcone e exhibits potent anti-inflammatory properties: Studies with phorbol ester-treated mouse skin and lipopolysaccharide-stimulated murine macrophages. Int J Mol Sci 2013;14:10926-43.
Wang QS, Cui YL, Dong TJ, Zhang XF, Lin KM. Ethanol extract from a Chinese herbal formula, "Zuojin Pill", inhibit the expression of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 mouse macrophages. J Ethnopharmacol 2012;141:377-85.
Legler DF, Bruckner M, Uetz-von Allmen E, Krause P. Prostaglandin E2 at new glance: Novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol 2010;42:198-201.
Nahar PP, Driscoll MV, Li L, Slitt AL, Seeram NP. Phenolic mediated anti-inflammatory properties of a maple syrup extract in RAW 264.7 murine macrophages. J Funct Foods 2014;6:126-36.
Jeong JB, Hong SC, Jeong HJ, Koo JS. Anti-inflammatory effect of 2-methoxy-4-vinylphenol via the suppression of NF-kB and MAPK activation, and acetylation of histone H3. Arch Pharm Res 2011;34:2109-16.
Allantaz F, Chaussabel D, Banchereau J, Pascual V. Microarray-based identification of novel biomarkers in IL-1-mediated diseases. Curr Opin Immunol 2007;19:623-32.
Antonelli A, Ferri C, Ferrari SM, Ghiri E, Goglia F, Pampana A, et al.
Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia. Arthritis Rheum 2009;60:3841-7.
Wang T, Wu F, Jin Z, Zhai Z, Wang Y, Tu B, et al.
Plumbagin inhibits LPS-induced inflammation through the inactivation of the nuclear factor-kappa B and mitogen activated protein kinase signaling pathways in RAW 264.7 cells. Food Chem Toxicol 2014;64:177-83.
Yoon SB, Lee YJ, Park SK, Kim HC, Bae H, Kim HM, et al.
Anti-inflammatory effects of Scutellaria baicalensis
water extract on LPS-activated RAW 264.7 macrophages. J Ethnopharmacol 2009;125:286-90.
Pereira SG, Oakley F. Nuclear factor-kB1: Regulation and function. Int J Biochem Cell Biol 2008;40:1425-30.
| Authors|| |
Dr. Sharida Fakurazi, is an Associate Professor at Pharmacology unit, Department of Human Anatomy at Faculty of Medicine and Health Science, Universiti Putra Malaysia (UPM), Malaysia and also holds the post of Head of the Laboratory of Vaccines and Immunotherapeutics, Institute of Bioscience at the same university. She has co-authored over 70 publications in internationally reputed peer-reviewed journals and holds 4 Malaysia patents. The current research interests mainly Drug research on bioactive phyto-constituents against drug induced hepatotoxicity; synthesis, characterize and development of nano-drugs against inflammation, hepato and neuro-toxicity.
Dr. Palanisamy Arulselvan received his Doctorate in the field of Biochemistry from the University of Madras, India and he was trained as a post-doctoral researcher at Academia Sinica, Taiwan. Currently, he is continuing his scientific research career as a Research Fellow at Institute of Bioscience, Universiti Putra Malaysia, Malaysia. He has published over 50 papers in internationally reputed journals, refereed proceedings and book chapter. His current research focuses on natural products based drug discovery; nano-drug delivery system and role of inflammatory signaling targets in diabetic wound healing.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
|This article has been cited by|
||Moringa oleifera and inflammation: a mini-review of its effects and mechanisms
| ||S.J. Ray,T.J. Wolf,C.N. Mowa |
| ||Acta Horticulturae. 2017; (1158): 317 |
|[Pubmed] | [DOI]|
||Modulation of murine intestinal immunity by Moringa oleifera extract in experimental hymenolepiasis nana
| ||M. Abdel-Latif,G. El-Shahawi,S.M. Aboelhadid,H. Abdel-Tawab |
| ||Journal of Helminthology. 2017; : 1 |
|[Pubmed] | [DOI]|
||Role of Antioxidants and Natural Products in Inflammation
| ||Palanisamy Arulselvan,Masoumeh Tangestani Fard,Woan Sean Tan,Sivapragasam Gothai,Sharida Fakurazi,Mohd Esa Norhaizan,S. Suresh Kumar |
| ||Oxidative Medicine and Cellular Longevity. 2016; 2016: 1 |
|[Pubmed] | [DOI]|